The longevity supplement market is undergoing a significant transformation, moving away from single-ingredient solutions toward comprehensive formulations that target multiple biological pathways of aging. This evolution is underscored by new market research from HTF Market Intelligence, which estimates the North American Longevity Hallmarks-of-Aging Nutraceuticals Market at $1.46 billion in 2025 and projects it could reach approximately $5.98 billion by 2034, a compound annual growth rate of 16.9%. The report identifies a shift from generic products to mechanism-based formulations that address individual hallmarks or combinations of aging pathways, with growing use of multi-ingredient formulations targeting antioxidant activity, mitochondrial function, metabolism, and cellular health. For AgeReverse, a Canadian longevity company expanding into the United States, this trend validates its foundational philosophy and its flagship product, RESURGE.
Central to this approach is the Hallmarks of Aging, a scientific framework that organizes the interconnected biological processes associated with aging. Originally introduced with nine hallmarks in 2013 and expanded to 12 in 2023, this framework has become an increasingly recognized reference point in aging research. The 12 hallmarks encompass genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. AgeReverse has built RESURGE around this comprehensive framework rather than focusing on a single ingredient.
RESURGE is a 90-capsule product that combines NMN, Resveratrol, Quercetin, Fisetin, CoQ10, Astragalus Extract, Hyaluronic Acid, Aronia Extract, and Noni Berry. According to the company, the formulation is designed to support all 12 hallmarks of aging through multiple mechanisms: providing antioxidant support to protect cells from oxidative stress, supporting nutrient metabolism and cellular health, aiding cardiovascular and immune function, promoting collagen formation and skin quality, maintaining healthy joints and connective tissue, and including herbal ingredients traditionally used as capillary and blood vessel protectants. The product consolidates what the company describes as more than 15 supplement protocols into a simplified three-capsule daily routine, manufactured in GMP-certified facilities in Ontario, Canada, using vegan capsules.
"Longevity is much more complex than any single ingredient or biological pathway," said Kubi Turkmen, Founder and CEO of AgeReverse. "The 12 Hallmarks give us a framework for looking at aging more comprehensively. That philosophy has been central to AgeReverse from the beginning and is why we believe the future of healthy aging will increasingly focus on multiple interconnected processes." Turkmen's perspective aligns with the HTF report's findings, which highlight a consumer and industry shift toward formulations that address the multifaceted nature of aging. The HTF Market Intelligence report underscores that this trend is not merely about growth but about a fundamental change in how longevity products are developed and marketed.
AgeReverse's U.S. expansion has accelerated in recent months. RESURGE is now available to American consumers through Amazon, and the company recently completed participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida, as it explores additional opportunities within the U.S. retail market. The company is also developing an inside-and-out approach to healthy aging built around the same 12 Hallmarks framework, with plans to include a Bioage Test, daily skincare products, professional mesotherapy products, and non-invasive mesotherapy technology alongside RESURGE. "We don't view healthy aging as something that can be addressed from only one direction," Turkmen added. "Our long-term vision is to connect internal wellness, skin care and professional aesthetic solutions through a science-first approach to the biological processes associated with aging." As scientific understanding of aging continues to develop, AgeReverse says it plans to continue building its product range around research into the biological mechanisms associated with healthy aging. The company's strategy reflects a broader industry recognition that addressing aging requires a multi-targeted approach, and its early alignment with the 12 Hallmarks framework may position it well as the market continues to evolve toward more sophisticated, science-based solutions.
